Use and interpretation of virological tests for hepatitis C.
about
Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for chronic hepatitis CImproved COBAS TaqMan Hepatitis C Virus Test (Version 2.0) for Use with the High Pure System: Enhanced Genotype Inclusivity and Performance Characteristics in a Multisite StudyKASL clinical practice guidelines: management of hepatitis CUpdate on hepatitis B and C virus diagnosisHepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsHepatitis C cirrhosis: New perspectives for diagnosis and treatmentDynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 AssaysSimultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV InfectionUse of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5' Untranslated Region SequencesFactors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic HepatitisPerformance of the Abbott Real-Time PCR Assay Using m2000sp and m2000rt for Hepatitis C Virus RNA QuantificationPrevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central BrazilPathogenesis of Hepatitis C Virus Infection in Tupaia belangeriFactors associated with seroprevalence of hepatitis C among dentists at a large Brazilian cityHepatitis C virus: Virology, diagnosis and treatmentDiagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis.Naturally occurring mutations in the nonstructural region 5B of hepatitis C virus (HCV) from treatment-naïve Korean patients chronically infected with HCV genotype 1b.Treatment of hepatitis C. The 2002 French consensus.Improving health care and laboratory medicine: the past, present, and future of molecular diagnostics.Hepatitis C virus: virology, diagnosis and management of antiviral therapy.Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver diseaseA practical approach to managing patients with HCV infection.Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.Development of a multiplex bead-based assay for detection of hepatitis C virusEvidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease.Multiplexed quantification of nucleic acids with large dynamic range using multivolume digital RT-PCR on a rotational SlipChip tested with HIV and hepatitis C viral loadMolecular beacon probes-base multiplex NASBA Real-time for detection of HIV-1 and HCV.Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA)Lack of evidence of hepatitis C and HIV co-infection among men who have sex with men in PeruPrevalence of HIV and HCV infections in two populations of Malian women and serological assays performances.Evaluation of operational chronic infection endpoints for HCV vaccine trialsHepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia.Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution.Hepatitis C virus infection in Egyptian children with type 1 diabetes mellitus: A single center study.Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Hepatitis C virus.Design and development of an in-house multiplex RT-PCR assay for simultaneous detection of HIV-1 and HCV in plasma samples.Comparison of serological and nucleic Acid based assays used to diagnose hepatitis C virus (HCV) infection in acute and chronic liver diseases.Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin.
P2860
Q24240315-C2CD9341-2773-4DD9-8643-17D74DACD4F2Q24289102-14595BBD-7342-4FC1-9A5C-FC145061CD04Q26752471-26DFE3E9-2681-456E-9F60-057E0FDF8EE1Q26777048-18F39333-43B3-417C-A5FC-72FDB0BBCD64Q26782033-B17BE6C2-87AD-4FA9-8348-D09F7E3D75B4Q26799924-66F7B027-A247-40BA-861A-3A7C9BC023B6Q27469461-F818E134-4B65-4485-A374-929F4F8B366EQ27469990-CE3BFEB2-0575-4577-B433-D9B52ECD1E6EQ27471998-6F7A1C72-1CAC-4525-91B9-3F38F048114AQ27478359-36C23BE6-9FF2-49D0-A670-A440B0AFD537Q27480999-4C5F7744-66AA-4AE8-86AF-0D696F645E6EQ27488563-EFFB28D7-B7E4-4D1C-A798-58EB2F7DC9F4Q27489255-11CE9552-FCFF-4655-8F42-DA44761B30B7Q27490544-29367621-66B5-47EB-9634-BEEB1B704394Q27490798-5B005CB6-10CB-413A-859A-E6C8764A4B4FQ28082000-7CC9FA15-6D19-4F7C-8F38-104FF3AA08EAQ30426257-A58A67E2-9D4F-4E1D-8509-5BB452DE0817Q31149778-CFCACCF3-91F3-4453-9660-6C1FF8C2E15BQ33195269-12D440C0-2BE3-4062-8E97-35045D31891CQ33945114-B3ADAAFE-0C7F-43AC-99DC-935E2366D58FQ34098547-064A11F7-DF16-4DE6-972C-85AB1F7C638EQ34485061-96814DB9-4C87-4D90-90E2-DF36A11E83F1Q34485082-3A64DA9C-A728-46CF-8FD6-2B4E075C2545Q34489239-43BD0ACD-0B89-4DC6-A1A7-9637239BD4BCQ35066209-FB35A947-17D5-4F78-9CC2-AA505C2EE5ADQ35237341-3F933B77-EC45-4054-B1B4-14065BACE9D3Q35551793-5C01CC46-2E95-461D-A8C7-774BFB67F5DDQ36211386-1B72AB69-F127-4A3B-8A96-9BE6AF22BB4DQ36240147-3DF7CDCA-375B-4A9B-85E0-4E64DF4A554EQ36405745-988EDC95-D4DD-4FC7-912B-D9577F95449FQ36561576-1C568715-FA71-48CA-A9E4-25809153C786Q36978905-31C8CAB6-6B74-4AB5-87D1-CF226FC43CDFQ37420620-C074C757-5224-49AC-B286-126294DFFEADQ37445272-59280813-D6F8-4DAA-BFCC-BD5C85968729Q37663438-1FCD9B9E-D1C6-452A-9A75-7C2F7AA44DD4Q37703702-1D167A45-4605-4D5A-8250-ABF81A9D24F8Q42109065-E5D4BF0B-8466-4F10-88E2-0EABC3DCD097Q42228568-DFE62B7A-AA8C-4FDC-8CE4-2CB1D12483E5Q42708052-5A6D4120-6E40-4710-961B-ABDF8B4C8F32Q42983450-7B08A022-4E61-4278-9965-98DB633984E7
P2860
Use and interpretation of virological tests for hepatitis C.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Use and interpretation of virological tests for hepatitis C.
@ast
Use and interpretation of virological tests for hepatitis C.
@en
Use and interpretation of virological tests for hepatitis C.
@nl
type
label
Use and interpretation of virological tests for hepatitis C.
@ast
Use and interpretation of virological tests for hepatitis C.
@en
Use and interpretation of virological tests for hepatitis C.
@nl
prefLabel
Use and interpretation of virological tests for hepatitis C.
@ast
Use and interpretation of virological tests for hepatitis C.
@en
Use and interpretation of virological tests for hepatitis C.
@nl
P2860
P356
P1433
P1476
Use and interpretation of virological tests for hepatitis C.
@en
P2093
Jean-Michel Pawlotsky
P2860
P304
P356
10.1053/JHEP.2002.36815
P407
P433
P577
2002-11-01T00:00:00Z